AMG National Trust Bank’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,642
| Closed | -$613K | – | 458 |
|
|
2025
Q1 | $613K | Sell |
9,642
-102
| -1% | -$6.94K | 0.02% | 331 |
|
|
2024
Q4 | $746K | Buy |
+9,744
| New | +$783K | 0.02% | 317 |
|
|
2024
Q1 | – | Sell |
-10,879
| Closed | -$930K | – | 438 |
|
|
2023
Q4 | $930K | Sell |
10,879
-105
| -1% | -$9.08K | 0.03% | 281 |
|
|
2023
Q3 | $984K | Buy |
10,984
+61
| +0.6% | +$5.45K | 0.03% | 270 |
|
|
2023
Q2 | $930K | Sell |
10,923
-146
| -1% | -$12.3K | 0.03% | 281 |
|
|
2023
Q1 | $916K | Sell |
11,069
-5,501
| -33% | -$445K | 0.03% | 299 |
|
|
2022
Q4 | $1.3M | Buy |
16,570
+196
| +1% | +$15.8K | 0.05% | 220 |
|
|
2022
Q3 | $1.21M | Buy |
16,374
+302
| +2% | +$21.7K | 0.05% | 231 |
|
|
2022
Q2 | $1.05M | Buy |
16,072
+65
| +0.4% | +$3.85K | 0.04% | 244 |
|
|
2022
Q1 | $1.01M | Sell |
16,007
-293
| -2% | -$15.9K | 0.03% | 268 |
|
|
2021
Q4 | $865K | Hold |
16,300
| – | – | 0.03% | 306 |
|
|
2021
Q3 | $1.15M | Buy |
+16,300
| New | +$1.03M | 0.04% | 251 |
|
|
2018
Q3 | – | Sell |
-8,308
| Closed | -$745K | – | 254 |
|
|
2018
Q2 | $745K | Sell |
8,308
-8
| -0.1% | -$676 | 0.05% | 171 |
|
|
2018
Q1 | $608K | Sell |
8,316
-11,242
| -57% | -$771K | 0.04% | 175 |
|
|
2017
Q4 | $1.14M | Buy |
19,558
+60
| +0.3% | +$3.16K | 0.07% | 135 |
|
|
2017
Q3 | $875K | Buy |
19,498
+606
| +3% | +$25.2K | 0.06% | 146 |
|
|
2017
Q2 | $746K | Buy |
18,892
+1,463
| +8% | +$60.1K | 0.05% | 159 |
|
|
2017
Q1 | $707K | Buy |
17,429
+1,883
| +12% | +$73.5K | 0.05% | 157 |
|
|
2016
Q4 | $625K | Sell |
15,546
-209
| -1% | -$7.88K | 0.05% | 163 |
|
|
2016
Q3 | $570K | Buy |
15,755
+197
| +1% | +$6.76K | 0.05% | 162 |
|
|
2016
Q2 | $451K | Sell |
15,558
-514
| -3% | -$15.5K | 0.04% | 189 |
|
|
2016
Q1 | $562K | Buy |
16,072
+1,397
| +10% | +$45.1K | 0.05% | 167 |
|
|
2015
Q4 | $473K | Buy |
14,675
+2,822
| +24% | +$91.5K | 0.04% | 181 |
|
|
2015
Q3 | $383K | Sell |
11,853
-41
| -0.3% | -$1.54K | 0.04% | 207 |
|
|
2015
Q2 | $492K | Sell |
11,894
-70
| -0.6% | -$2.95K | 0.05% | 183 |
|
|
2015
Q1 | $537K | Buy |
11,964
+1,388
| +13% | +$58K | 0.05% | 168 |
|
|
2014
Q4 | $396K | Sell |
10,576
-984
| -9% | -$36K | 0.04% | 201 |
|
|
2014
Q3 | $404K | Sell |
11,560
-2,094
| -15% | -$74.7K | 0.04% | 196 |
|
|
2014
Q2 | $482K | Buy |
13,654
+6
| +0% | +$200 | 0.05% | 188 |
|
|
2014
Q1 | $445K | Sell |
13,648
-248
| -2% | -$9.48K | 0.05% | 189 |
|
|
2013
Q4 | $585K | Buy |
+13,896
| New | +$572K | 0.07% | 165 |
|
Other funds holding HAE
RRAM
RA
AMG National Trust Bank's HAE Position: Q2 2025 in Review
AMG National Trust Bank sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 9,642 shares — an estimated $613K sold.
AMG National Trust Bank first reported a position in HAE in Q4 2013 and held it in 31 quarters. The position peaked at $1.3M in Q4 2022. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.
- AMG National Trust Bank reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
- AMG National Trust Bank sold 9,642 Haemonetics shares in Q2 2025, an estimated $613K.
- AMG National Trust Bank first reported a position in Haemonetics in Q4 2013 and held it in 31 quarters.
- AMG National Trust Bank's Haemonetics position peaked at $1.3M in Q4 2022.
- 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.
Based on AMG National Trust Bank's 13F filing for Q2 2025, filed 4 Aug 2025.